# Boster Bio Expands Access to Validated Human TNF-α PicoKine ELISA Kit for Reliable Cytokine Quantification

- Link: https://www.thailand-business-news.com/pr-news/boster-bio-expands-access-to-validated-human-tnf-%ce%b1-picokine-elisa-kit-for-reliable-cytokine-quantification
- Published: 2026-07-09T18:33:00+07:00
- Author: MarketersMEDIA Newswire

_Boster Biological Technology, a life science reagent manufacturer based in Pleasanton,
California, has expanded access to its validated Human TNF-α PicoKine™ ELISA Kit,
a quantitative sandwich ELISA developed to measure human TNF-α in cell culture supernatants,
serum, and plasma samples._

Pleasanton, California, United States, July 9, 2026 — Measuring TNF-α accurately
sounds straightforward until researchers begin comparing data across experiments.
Serum and plasma matrices can affect cytokine recovery. Low-abundance samples may
approach assay detection limits. Standard curves can shift when protocols, operators,
or reagent lots change. For laboratories studying inflammatory signaling, immune
activation, or therapeutic response, this variability is more than a technical inconvenience.
It can complicate interpretation of biomarker data and delay follow-up studies.

![](https://storage.googleapis.com/mmstudio-images/gallery/FBJ0bZbYzjX5jZyh6O0I2pqTA2B3/
89197336-1783596814-1.jpg)

Boster Biological Technology, a life science reagent manufacturer based in Pleasanton,
California, has expanded access to its validated **[Human TNF-α PicoKine™ ELISA Kit](https://www.bosterbio.com/human-tnf-alpha-picokine-trade-elisa-kit-ek0525-boster.html)**,
a quantitative sandwich ELISA developed to measure human TNF-α in cell culture supernatants,
serum, and plasma samples. Complete product specifications and ordering information
are available at[ ](https://www.bosterbio.com/human-tnf-alpha-picokine-trade-elisa-kit-ek0525-boster.html)**
[https://www.bosterbio.com/human-tnf-alpha-picokine-trade-elisa-kit-ek0525-boster.htm](https://www.bosterbio.com/human-tnf-alpha-picokine-trade-elisa-kit-ek0525-boster.html)**
[l](https://www.bosterbio.com/human-tnf-alpha-picokine-trade-elisa-kit-ek0525-boster.html).

TNF-α, also known as tumor necrosis factor alpha, remains one of the most widely
measured cytokines in inflammation and immunology research. It is released during
innate immune activation and is frequently measured in studies of autoimmune disease,
infectious disease, cancer immunology, sepsis, cytokine release, and anti-inflammatory
therapeutic development. Because TNF-α levels can change rapidly after immune stimulation,
researchers often rely on ELISA-based quantification to compare cytokine expression
across samples, time points, and treatment groups.

The Human TNF-α PicoKine™ ELISA Kit is designed for researchers who need a sensitive
TNF alpha ELISA kit for human serum, plasma, and cell culture supernatants. The 
kit offers 1 pg/mL sensitivity, with reported assay ranges of 7.8 pg/mL to 500 pg/
mL for serum and plasma samples and 15.6 pg/mL to 1000 pg/mL for cell culture supernatants.
This range supports quantitative TNF-α measurement in both circulating sample matrices
and in vitro stimulation studies.

Boster’s PicoKine™ ELISA platform is positioned around assay sensitivity, reproducibility,
and consistent lot performance. For TNF-α studies, this is particularly important
when projects involve longitudinal sampling, multi-site collaborations, or repeated
testing across several experimental batches. A validated cytokine ELISA kit can 
reduce the need for repeated assay optimization and help researchers maintain comparability
across related experiments.

The kit is commonly used in research workflows evaluating chronic inflammation, 
autoimmune signaling, macrophage activation, cancer-associated inflammation, cytokine
release, and drug response. In preclinical studies, quantitative TNF-α measurement
can help assess whether an intervention suppresses or amplifies inflammatory signaling.
In biomarker discovery programs, consistent TNF-α detection supports comparison 
across patient cohorts, treatment groups, or disease models.

Many inflammatory signaling studies also combine ELISA-based cytokine quantification
with protein expression analysis. For example, researchers measuring TNF-α secretion
may also evaluate downstream pathway activation through Western blotting, including
signaling proteins involved in NF-κB, MAPK, or apoptosis-related pathways. Laboratories
requiring complementary protein detection support can access **[Boster’s Western blotting services](https://www.bosterbio.com/services/assay-services/western-blotting-service)**
at **https://www.bosterbio.com/services/assay-services/western-blotting-service**.

Although multiplex cytokine platforms continue to evolve, TNF-α remains a foundational
inflammatory biomarker because of its central role in immune regulation and disease
pathogenesis. Quantitative ELISA remains a practical and widely used approach for
targeted cytokine measurement when sensitivity, standard curve reliability, and 
reproducibility are priorities.

Researchers can explore additional ELISA kits, antibodies, assay services, and protein
detection reagents through Boster Biological Technology at** https://www.bosterbio.
com/**.

**About Boster Biological Technology**

Boster Biological Technology is a life science manufacturer based in Pleasanton,
California. The company produces ELISA kits, antibodies, and research reagents for
academic and commercial laboratories. Technical support for assay selection, protocol
development, and troubleshooting is available through the company’s research services
team.

Contact Info: 
Name: C. J. XiaEmail: [Send Email](https://send.releasecontact.com/89197336)
Organization: Boster Biological TechnologyAddress: 3942 Valley Ave., Pleasanton,
CA 94566Phone: (888) 466-3604Website: [https://www.bosterbio.com/](https://www.bosterbio.com/)

Release ID: 89197336

Should any problems, inaccuracies, or doubts arise from the content contained within
this press release, we kindly request that you inform us immediately by contacting
[error@releasecontact.com](https://www.thailand-business-news.com/pr-news/error@releasecontact.com)(
it is important to note that this email is the authorized channel for such matters,
sending multiple emails to multiple addresses does not necessarily help expedite
your request). Our dedicated team will promptly address your concerns within 8 hours,
taking necessary steps to rectify identified issues or assist with the removal process.
Providing accurate and dependable information is at the core of our commitment to
our readers.

**Source** : [Boster Bio Expands Access to Validated Human TNF-α PicoKine ELISA Kit for Reliable Cytokine Quantification](https://news.marketersmedia.com/boster-bio-expands-access-to-validated-human-tnf-a-picokine-elisa-kit-for-reliable-cytokine-quantification/89197336?rand=206000)

    ```wp-block-verse
    The information provided in this article was created by MarketersMEDIA Newswire, our news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of Thailand Business News.
    ```